Literature DB >> 25313569

Carboplatin hypersensitivity: evaluation and successful desensitization protocol.

Ilan Bruchim1, Arnon Goldberg, Ami Fishman, Ronit Confino-Cohen.   

Abstract

AIM: Carboplatin-induced immediate hypersensitivity reactions are relatively common among patients with gynecological malignancies. Once this occurs, the patient might be at risk for future carboplatin-induced reactions. This study evaluated the efficacy of allergic consultation, carboplatin skin testing and desensitization as a single intervention strategy in this population.
METHODS: Patients with a well-documented immediate reaction to carboplatin were offered allergy consultation, carboplatin skin testing and a desensitization plan in a single visit between scheduled chemotherapy sessions.
RESULTS: Fifty-five patients with an immediate reaction were evaluated. After allergist assessment, 44 (89%) of 49 patients skin tested had a positive result. A total of 207 carboplatin desensitization cycles were administered to 49 women. Among them, 10 patients had a mild immediate hypersensitivity reaction during desensitization. Five patients subsequently tolerated carboplatin administered in the prolonged desensitization protocol.
CONCLUSIONS: In the data presented, we propose a strategy that is both cost effective and very convenient for the patient. The diagnostic procedure, including allergist consultation and skin test, can be completed in less than 2 h. In most cases where carboplatin is indispensable, desensitization can be administered without overnight hospitalization.

Entities:  

Keywords:  allergic evaluation; carboplatin allergy; desensitization; ovarian cancer; skin test

Mesh:

Substances:

Year:  2014        PMID: 25313569     DOI: 10.2217/imt.14.71

Source DB:  PubMed          Journal:  Immunotherapy        ISSN: 1750-743X            Impact factor:   4.196


  3 in total

Review 1.  Drug Desensitizations for Chemotherapy: Safety and Efficacy in Preventing Anaphylaxis.

Authors:  Joana Caiado; Mariana C Castells
Journal:  Curr Allergy Asthma Rep       Date:  2021-07-07       Impact factor: 4.806

2.  Risk Factors of Hypersensitivity to Carboplatin in Patients with Gynecologic Malignancies.

Authors:  Yu-Hsiao Tai; Yi-Jou Tai; Heng-Cheng Hsu; Shu-Ping Lee; Yun-Yuan Chen; Ying-Cheng Chiang; Yu-Li Chen; Chi-An Chen; Wen-Fang Cheng
Journal:  Front Pharmacol       Date:  2017-11-06       Impact factor: 5.810

Review 3.  Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists' arsenal.

Authors:  Panagiota Papanagnou; Panagiotis Baltopoulos; Maria Tsironi
Journal:  Ther Clin Risk Manag       Date:  2015-05-18       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.